Related Experiment Video

Updated: Apr 12, 2026

An Oncogenic Hepatocyte-Induced Orthotopic Mouse Model of Hepatocellular Cancer Arising in the Setting of Hepatic Inflammation and Fibrosis
06:38

An Oncogenic Hepatocyte-Induced Orthotopic Mouse Model of Hepatocellular Cancer Arising in the Setting of Hepatic Inflammation and Fibrosis

Published on: September 12, 2019

9.7K

Liver receptor homolog-1 (LRH-1): a potential therapeutic target for cancer

Christina Nadolny1, Xiaoqun Dong

  • 1a Department of Biomedical and Pharmaceutical Sciences; University of Rhode Island ; Kingston , RI , USA.

Cancer Biology & Therapy
|May 8, 2015
PubMed

Insights

Liver receptor homolog-1 (LRH-1) is crucial for development and homeostasis. Its dysregulation in cancer promotes proliferation and metastasis, highlighting LRH-1 as a therapeutic target.

Area of Science:

  • Molecular Biology
  • Oncology
  • Endocrinology

Background:

  • Liver receptor homolog-1 (LRH-1) is a nuclear receptor vital for embryonic development and adult homeostasis.
  • While its role in normal breast, pancreas, and intestine is known, its dysregulation in pathological conditions requires further investigation.
  • LRH-1 is implicated in pancreatic, breast, and gastrointestinal cancers, promoting tumor initiation and progression.

Purpose of the Study:

  • To explore the pathological roles of LRH-1 in cancer.
  • To investigate LRH-1 as a potential therapeutic target for cancer treatment.
  • To identify and develop LRH-1 ligands (agonists and antagonists).

Main Methods:

  • Review of existing mechanistic studies on LRH-1 function in cancer.
  • Computational-based structural analysis for ligand identification.
  • Exploration of LRH-1 agonists and antagonists.

Main Results:

  • LRH-1 dysregulation contributes to cell proliferation and metastasis in various cancers.
  • Identification of potential endogenous and synthetic ligands for LRH-1.
  • Structural analysis aids in understanding ligand-receptor interactions.

Conclusions:

  • LRH-1 plays a significant role in the initiation and progression of pancreatic, breast, and gastrointestinal cancers.
  • Targeting LRH-1 with specific ligands presents a promising therapeutic strategy for cancer treatment.
  • Further research into LRH-1 ligand identification and its pathological roles is warranted for developing novel cancer therapies.
Keywords:
breast cancergastrointestinal cancerliver receptor homolog-1 (LRH-1)pancreatic cancerwnt/β-catenin

More Related Videos

Establishment of Hepatocarcinoma in BALB/c-nu Mice and Investigation of the Therapeutic Effect of the Sanleng Jiashen Formula09:03

Establishment of Hepatocarcinoma in BALB/c-nu Mice and Investigation of the Therapeutic Effect of the Sanleng Jiashen Formula

Published on: January 26, 2024

808
A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma12:24

A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma

Published on: September 30, 2021

6.3K

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
9.2K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

1.8K
lncRNA - Long Non-coding RNAs02:39

lncRNA - Long Non-coding RNAs

In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
10.2K
Liver Regeneration01:24

Liver Regeneration

The liver is an important organ in vertebrates that plays an essential role in metabolism. It is also responsible for storing and redistributing nutrients such as carbohydrates, fats, and vitamins in the body. Additionally, the liver releases bile salts which are critical for digesting food and eliminating toxic metabolites from the body.
Cells of Liver
The liver comprises four major types of cells— hepatocytes, stellate, Kupffer, and sinusoidal endothelial cells. The hepatocytes are...
5.3K
Transducer Mechanism: Enzyme-Linked Receptors01:27

Transducer Mechanism: Enzyme-Linked Receptors

Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
5.0K
Transducer Mechanism: Nuclear Receptors01:31

Transducer Mechanism: Nuclear Receptors

Nuclear receptors, or NRs, are unique transcription factors that regulate gene transcription and affect the cellular pathways involved in reproduction, development, or metabolism. Their ability to be stimulated by small lipophilic ligands and control vital cellular processes makes them ideal drug targets. Nearly 10-15% of currently prescribed drugs target these receptors.
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
6.3K